BMJ Best Practice

参考文献

关键文献

Hancock BW. Staging and classification of gestational trophoblastic disease. Clin Obstet Gynecol Best Pract Res. 2003;17:869-883.

Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003;110:22-26.

Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176-187.

Soper JT, Mutch DG, Schink JC. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol. 2004;93:575-585.

参考文章

1.  Hancock BW. Staging and classification of gestational trophoblastic disease. Clin Obstet Gynecol Best Pract Res. 2003;17:869-883.

2.  Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol. 2003;46:541-556.

3.  Loukovaara M, Pukkala E, Lehtovirta P, et al. Epidemiology of hydatidiform mole in Finland, 1975 to 2001. Eur J Gynaecol. Oncol. 2005;26:207-208.

4.  Altieri A, Franceschi S, Ferlay J, et al. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670-678.

5.  Kim SJ, Bae SN, Kim JH, et al. Epidemiology and time trends of gestational trophoblastic disease in Korea. Int J Gynaecol Obstet. 1998;60(suppl 1):S33-S38.

6.  Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003;110:22-26.

7.  Altman AD, Bentley B, Murray S, et al. Maternal age-related rates of gestational trophoblastic disease. Obstet Gynecol. 2008;112:244-250.

8.  Di Cintio E, Parazzini F, Rosa C, et al. The epidemiology of gestational trophoblastic disease. Gen Diagn Pathol. 1997;143:103-108.

9.  Davis JR, Surwit EA, Garay JP, et al. Sex assignment in gestational trophoblastic neoplasia. Am J Obstet Gynecol. 1984;148:722-725.

10.  Szulman AE, Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol. 1978;131:665-671.

11.  Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evaluation of the complete and partial mole. Am J Obstet Gynecol. 1978;132:20-27.

12.  Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176-187.

13.  Schlaerth JB, Morrow CP, Montz FJ, et al. Initial management of hydatidiform mole. Am J Obstet Gynecol. 1988;158:1299-1306.

14.  Berkowitz RS, Tuncer ZS, Bernstein MR, et al. Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol. 2000;27:678-685.

15.  Lorigan PC, Sharma S, Bright N, et al. Characteristics of women with recurrent molar pregnancies. Gynecol Oncol. 2000;78:288-292.

16.  Sand PK, Lurain JR, Brewer JI. Repeat gestational trophoblastic disease. Obstet Gynecol. 1984;63:140-144.

17.  Berkowitz RS, Cramer DW, Bernstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol. 1985;152:1016-1020.

18.  Soto-Wright V, Bernstein M, Goldstein DP, et al. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995;86:775-779.

19.  Soper JT, Mutch DG, Schink JC. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol. 2004;93:575-585.

20.  Norman RJ, Green-Thompson RW, Jialal I, et al. Hyperthyroidism in gestational trophoblastic neoplasia. Clin Endocrinol (Oxf). 1981;15:395-401.

21.  Yamazaki K, Sato K, Shizume K, et al. Potent thyrotropic activity of human chorionic gonadotropin variants in terms of 125I incorporation and de novo synthesized thyroid hormone release in human thyroid follicles. J Clin Endocrinol Metab. 1995;80:473-479.

22.  Coukos G, Makrigiannakis A, Chung J, et al. Complete hydatidiform mole. A disease with a changing profile. J Reprod Med. 1999;44:698-704.

23.  Soper JT, Lewis JT, Hammond CB. Gestational trophoblastic disease. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1997:1039-1077.

24.  Kallen B. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol. 1987;26:291-302.

25.  American College of Radiology. ACR-ACOG-AIUM-SRU practice parameter for the performance of obstetrical ultrasound. 2014. http://www.acr.org/ (last accessed 5 March 2015).

26.  Twiggs LB, Morrow CP, Schlaerth JB. Acute pulmonary complications of molar pregnancy. Am J Obstet Gynecol. 1979;135:189-194.

27.  Curry SL, Hammond CB, Tyrey L, et al. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol. 1975;45:1-8.

28.  Tidy JA, Gillespie AM, Bright N, et al. Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol. 2000;78:309-312.

29.  Lao TT, Lee FH, Yeung SS. Repeat curettage after evacuation of hydatidiform mole. An appraisal. Acta Obstet Gynecol Scand. 1987;66:305-307.

30.  Berkowitz RS, Im SS, Bernstein MR, et al. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 1998;43:81-86.

31.  Montz FJ, Schlaerth JB, Morrow CP. The natural history of theca lutein cysts. Obstet Gynecol. 1988;72:247-251.

32.  Fu J, Fang F, Xie L, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2012;(10):CD007289.

33.  European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013. http://www.ema.europa.eu (last accessed 4 April 2014).

34.  Asherman JG. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1950;57:892-896.

35.  Lurain JR, Brewer JI. Invasive mole. Semin Oncol. 1982;9:174-180.

36.  Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. J Reprod Med. 2002;47:445-450.

37.  Mazur MT, Kurman RJ. Choriocarcinoma and placental site tumor. In: Szulman AE, Bauschman HJ, eds. Gestational trophoblastic disease. New York, NY: Springer-Verlag; 1987:45-68.

使用此内容应接受我们的免责声明